Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection

Viral Immunology

Volumn 24, Issue 4, 2011, Pages 273-280

  Tsai, Ching Yi ^a   Hu, Zhuting ^a   Zhang, Weijun ^a   Usherwood, Edward J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GRANZYME; INTERLEUKIN 2 RECEPTOR ANTIBODY; PERFORIN; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GAMMAHERPESVIRINAE; GENETIC VARIABILITY; HERPES VIRUS INFECTION; IMMUNOTHERAPY; KNOCKOUT GENE; MOUSE; MURINE GAMMAHERPESVIRUS 68 INFECTION; NATURAL KILLER CELL; NONHUMAN; RESPIRATION CONTROL; RESPIRATORY TRACT INFECTION; SPLEEN CELL; STRAIN DIFFERENCE; T CELL DEPLETION; TREATMENT DURATION; VIRUS CULTURE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; HERPESVIRIDAE INFECTIONS; IMMUNOTHERAPY; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PERFORIN; RESPIRATORY TRACT INFECTIONS; RHADINOVIRUS; RODENT DISEASES; SURVIVAL ANALYSIS;

MURINAE; MURINE HEPATITIS VIRUS; MUS;

EID: 80051762062     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0004     Document Type: Article

References (41)

1. Buer J, and Balling R: Mice, microbes and models of infection. Nat Rev Genet 2003;4:195-205. (Pubitemid 36267890)
2. Cantin E, Tanamachi B, and Openshaw H: Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol 1999;73:3418-3423. (Pubitemid 29135735)
3. Cardin RD, Brooks JW, Sarawar SR, and Doherty PC: Progressive loss of CD8+ T cell-mediated control of a gammaherpesvirus in the absence of CD4+ T cells. J Exp Med 1996;184:863-871.
4. Durbin RK, Mertz SE, Koromilas AE, and Durbin JE: PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol 2002;15: 41-51. (Pubitemid 34273437)
5. Dutia BM, Clarke CJ, Allen DJ, and Nash AA: Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol 1997;71:4278-4283. (Pubitemid 27204114)
6. Ehtisham S, Sunil-Chandra NP, and Nash AA: Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol 1993;67:5247-5252. (Pubitemid 23241355)
7. Flano E, Husain SM, Sample JT, Woodland DL, and Blackman MA: Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 2000;165:1074-1081. (Pubitemid 30484779)
8. Flano E, Kim IJ, Woodland DL, and Blackman MA: Gammaherpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 2002;196: 1363-1372. (Pubitemid 35375555)
9. Fuse S, Obar JJ, Bellfy S, Leung EK, Zhang W, and Usherwood EJ: CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68. J Virol 2006;80:9159-9170. (Pubitemid 44359988)
10. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, and Durbin JE: The role of interferon in influenza virus tissue tropism. J Virol 1998;72:8550-8558. (Pubitemid 28471792)
11. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, Williams BR, and Chisari FV: Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 2002;76:2617-2621. (Pubitemid 34184846)
12. Johannessen I, Asghar M, and Crawford DH: Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice. Br J Haematol 2000;109:600-610. (Pubitemid 30415188)
13. Kagi D, Seiler P, Pavlovic J, Ledermann B, Burki K, Zinkernagel RM, and Hengartner H: The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995;25:3256-3262.
14. Khakoo SI, Thio CL, Martin MP, et al.: HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-874. (Pubitemid 39038423)
15. Kim IJ, Flano E, Woodland DL, and Blackman MA: Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol 2002;168:3958-3964. (Pubitemid 34298400)
16. Lam-Yuk-Tseung S, and Gros P: Genetic control of susceptibility to bacterial infections in mouse models. Cell Microbiol 2003;5:299-313. (Pubitemid 37009908)
17. Lee KS, Cool CD, and van Dyk LF: Murine gammaherpesvirus 68 infection of gamma interferon-deficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes. J Virol 2009;83:11397-11401.
18. Lotz M, Tsoukas CD, Fong S, Carson DA, and Vaughan JH: Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur J Immunol 1985;15:520-525. (Pubitemid 15071586)
19. McClary H, Koch R, Chisari FV, and Guidotti LG: Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 2000;74:2255-2264. (Pubitemid 30091480)
20. Molloy MJ, Zhang W, and Usherwood EJ: Cutting edge: IL-2 immune complexes as a therapy for persistent virus infection. J Immunol 2009;182:4512-4515.
21. Nansen A, Jensen T, Christensen JP, Andreasen SO, Ropke C, Marker O, and Thomsen AR: Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus. J Immunol 1999;163:6114-6122.
22. Nash AA, Dutia BM, Stewart JP, and Davison AJ: Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 2001;356:569-579. (Pubitemid 32442753)
23. Obar JJ, Crist SG, Leung EK, and Usherwood EJ: IL-15- independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection. J Immunol 2004;173: 2705-2714. (Pubitemid 39063132)
24. Olivadoti M, Toth LA, Weinberg J, and Opp MR: Murine gammaherpesvirus 68: a model for the study of Epstein-Barr virus infections and related diseases. Comp Med 2007;57:44-50. (Pubitemid 46328518)
25. Pozharskaya VP, Weakland LL, and Offermann MK: Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells. J Gen Virol 2004;85:2779-2787. (Pubitemid 39360020)
26. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Hamilton-Easton AM, Mo XY, and Doherty PC: Gammainterferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol 1997;71:3916-3921. (Pubitemid 27172406)
27. Srivastava B, Blazejewska P, Hessmann M, et al.: Host genetic background strongly influences the response to influenza a virus infections. PLoS One 2009;4:e4857.
28. Steed A, Buch T, Waisman A, and Virgin HWT: Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. J Virol 2007;81:6134-6140. (Pubitemid 46847051)
29. Steed AL, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, Rochford R, and Virgin HWT: Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 2006;80:192-200.
30. Stewart JP, Usherwood EJ, Ross A, Dyson H, and Nash T: Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 1998;187:1941-1951. (Pubitemid 28285564)
31. Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, and Degli-Esposti MA: The roles of interferongamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol 2009;87:559-566.
32. Sunil-Chandra NP, Efstathiou S, Arno J, and Nash AA: Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol 1992;73:2347-2356.
33. Sunil-Chandra NP, Efstathiou S, and Nash AA: Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 1992;73:3275-3279. (Pubitemid 23014183)
34. Tarakanova VL, Suarez F, Tibbetts SA, et al.: Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol 2005;79:14668-14679. (Pubitemid 41636265)
35. Tibbetts SA, van Dyk LF, Speck SH, and Virgin HWT: Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol 2002;76:7125-7132. (Pubitemid 41246226)
36. Tripp RA, Hamilton-Easton AM, Cardin RD, et al.: Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med 1997;185:1641-1650. (Pubitemid 27203260)
37. Usherwood EJ, Brooks JW, Sarawar SR, et al.: Immunological control of murine gammaherpesvirus infection is independent of perforin. J Gen Virol 1997;78:2025-2030. (Pubitemid 27367690)
38. Usherwood EJ, Stewart JP, Robertson K, Allen DJ, and Nash AA: Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol 1996;77:2819-2825. (Pubitemid 26390583)
39. Weck KE, Kim SS, Virgin HI, and Speck SH: Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 1999;73:3273-3283. (Pubitemid 29135720)
40. Weinberg JB, Lutzke ML, Alfinito R, and Rochford R: Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus. Viral Immunol 2004;17:69-77. (Pubitemid 38338463)
41. Yao QY, Tierney RJ, Croom-Carter D, et al.: Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 1996;70:4884-4894